SCHEMBL10128530

SCHEMBL10128530

Cc1cc(Nc2nc(N[C@H]3CCCC[C@@H]3N)[nH]c(=O)c2C(N)=O)ccc1S(=O)(=O)N1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SYK P43405 18/20 0.61
FER P16591 2/20 0.44
ZAP70 P43403 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128535 0.90 SYK (0.64) SYKFERZAP70
SCHEMBL10156251 0.90 SYK (0.65) SYKZAP70
SCHEMBL10128663 0.88 SYK (0.61) SYKFERZAP70
SCHEMBL10128413 0.85 SYK (0.55) SYK
SCHEMBL10128677 0.85 SYK (0.61) SYKFER
SCHEMBL10128685 0.83 SYK (0.61) SYKFERZAP70
SCHEMBL10128698 0.82 SYK (0.64) SYKFER
SCHEMBL10126522 0.81 MAPT (0.42)
SCHEMBL2715387 0.81 SYK (0.79) SYKFERZAP70
SCHEMBL10128227 0.80 SYK (0.67) SYKZAP70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 SYK 2200/4885FER 160/4885ZAP70 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.